Description
Femara (Letrozole) Coated Tablets 2.5 mg.
Introduction:
Femara (Letrozole) is an oral medication that belongs to a class of drugs known as aromatase inhibitors. It is commonly used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Letrozole works by reducing the levels of estrogen in the body, which can help slow or stop the growth of hormone-sensitive tumors.
Description:
Femara comes in the form of coated tablets, each containing 2.5 mg. of letrozole as the active ingredient. These tablets are round and white in color, with a smooth coating for easy swallowing. Each pack contains 30 tablets, providing a month’s supply of medication when taken as prescribed.
Indications:
Femara is indicated for the treatment of postmenopausal women with hormone receptor-positive breast cancer. It is often prescribed as part of adjuvant therapy following surgery or as a first-line treatment for metastatic breast cancer. Letrozole may also be used off-label for other conditions under the guidance of a healthcare provider.
Dosage and Administration:
The recommended dose of Femara is 2.5 mg. taken once daily, with or without food. It is important to follow the dosage instructions provided by your healthcare provider to ensure the medication is effective and safe for you. Do not adjust the dosage or stop taking Femara without consulting your doctor.
Contraindications:
Femara should not be used by individuals who are allergic to letrozole or any of the other ingredients in the tablets. It is contraindicated in premenopausal women, pregnant women, and women who are breastfeeding. Letrozole may interact with certain medications, so inform your doctor of all the drugs you are taking before starting treatment.
Side Effects:
Common side effects of Femara may include hot flashes, fatigue, joint pain, headache, and nausea. These side effects are usually mild and temporary, but if they persist or worsen, contact your healthcare provider. Serious side effects such as bone fractures, blood clots, or liver problems are rare but require immediate medical attention.
Warnings and Precautions:
Prior to starting treatment with Femara, inform your doctor if you have a history of osteoporosis, liver disease, or any other medical conditions. Letrozole may increase the risk of osteoporosis, so bone density monitoring may be recommended during therapy. Avoid becoming pregnant while taking Femara and use effective contraception if you are of childbearing potential.
Storage:
Store Femara tablets at room temperature, away from moisture and heat. Keep the medication in its original packaging and out of reach of children and pets. Do not use expired medication or dispose of unused tablets in a safe and environmentally friendly manner.
Conclusion:
Femara (Letrozole) coated tablets 2.5 mg. are a valuable treatment option for postmenopausal women with hormone receptor-positive breast cancer. By inhibiting estrogen production, letrozole can help slow the progression of the disease and improve outcomes for patients. It is essential to take Femara as directed by your healthcare provider and communicate any concerns or side effects promptly. Always consult a healthcare professional for personalized advice regarding the use of Femara and its potential benefits and risks.
